Consumer telehealth · Physician-led GLP-1 telehealth
Ivím Health
Ivím Health is a physician-led telehealth clinic for weight loss and hormone health, where licensed providers prescribe GLP-1 medications, including compounded semaglutide and tirzepatide, alongside coaching on nutrition and movement.
Strong fit
- Patients who want a provider to adjust their GLP-1 dose over months
- Cash-pay patients who can prepay a long program for lower monthly medication prices
- People who want coaching and a member community with the prescription
Weak fit
- Patients who want one all-in monthly price
- Anyone who does not want a membership fee on top of medication
- Patients who need in-person visits
Bottom line
Ivím Health is a bootstrapped weight-loss and hormone telehealth clinic from Columbus, Ohio, that pairs GLP-1 prescriptions with ongoing physician follow-up and coaching. It suits cash-pay patients who want a provider to adjust their plan over time. Patients who want one all-in monthly price should compare it with Henry Meds, which bundles visits and medication.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Ivím Health is used by adults who want prescription weight-loss medication with more support than a one-time online consult. A patient meets a board-certified provider, gets a plan that can include compounded semaglutide or tirzepatide, and keeps the same care team as the dose changes. The company says it has served more than 470,000 patients with about 100 providers, and in 2026 it added women's and men's hormone programs.
For patients who prepay, Ivím is one of the cheaper ways to get compounded GLP-1 medication. Its homepage lists 12-month programs of compounded tirzepatide at $117 a month and compounded semaglutide at $65 a month, and its weight-loss page lists starting prices of $140 a month for semaglutide and $192 for tirzepatide with the program fee included. A $75 monthly membership is required to receive prescriptions. Henry Meds lists GLP-1 programs from $179 a month with visits and medication included, so the cheaper choice depends on plan length.
The closest competitors are Henry Meds, Found, Mochi Health, and GobyMeds.
Brothers Anthony Kantor and Dr. Taylor Kantor founded Ivím in Columbus, Ohio, in 2021. Taylor Kantor trained as a cardiac and thoracic surgeon at the University of Michigan, and Dr. Jessica Duncan, a board-certified obesity medicine physician, is chief medical officer. The company has raised no outside capital, says on its About page that it turned down a nine-figure acquisition offer, and ranked No. 38 on the 2026 Inc. 5000 list of fastest-growing private companies.
Ivím reports outcomes from two retrospective studies of its own patients published in the journal Obesity Pillars in June 2025 and March 2026: average total body weight loss of 27% on tirzepatide and 22% on semaglutide. These are observational studies, not randomized trials, and they cover both branded and compounded drugs. Compounded semaglutide and tirzepatide are not FDA-approved finished drugs.
The complaints center on billing. Several patients say the $75 membership kept charging after a prepaid program ended, and others report pharmacy changes between shipments. Ivím's membership page says the fee auto-renews until canceled and must run the length of the clinical program.
What patients say
Patients on Trustpilot rate Ivím Health 4.9 from 39,956 reviews. Here is what they like and dislike.
"I’ve never had to worry about payments, lost orders, etc like I’ve had with other telehealth companies, IVIM is seriously the best" Trustpilot
"Lana was sweet and helpful and clear in explaining next steps and what to expect with my shipment and dosage." Trustpilot
"I bought a multi-month program with IViM but after it was complete they kept charging me a $75 “membership fee” each month." Trustpilot
"When I renewed, you sent me a less potent dose and from a different pharmacy." Trustpilot
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Ivím Health | 7.5 | 7.2 |
| Found | 7.4 | 7.2 |
| Mochi Health | 7.0 | 6.6 |
| Henry Meds | 6.7 | 6.3 |
| GobyMeds | 6.6 | 6.5 |
Pricing
| Item | Detail |
|---|---|
| Model | Ivím charges a $75 monthly membership for its care team, plus medication billed separately, often prepaid as a multi-month program. |
| What usually drives cost | For Ivím, cost depends on the medication, the program length you prepay, and how long the membership runs. |
| What to ask before you buy | Ask Ivím for the total of membership and medication over your full program, and how to stop the membership when the program ends. |
| Note | Compounded semaglutide and tirzepatide are not FDA-approved finished drugs. |
| Published pricing | Ivím lists 12-month programs of compounded tirzepatide at $117 a month and compounded semaglutide at $65 a month. Membership is $74.99 a month, and the Men's Hormone Health lab kit costs $99. |
Leadership
Anthony KantorCo-founder and CEO
Dr. Taylor KantorCo-founder and Chief Innovation Officer- Dr. Jessica DuncanChief Medical Officer
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.